Alicia Palmieri

Papers

1

Total Citations

5

H-Index

1

About

Alicia Palmieri is a leading voice in gynecologic oncology, with a focused research agenda on optimizing surgical outcomes and perioperative care for women with endometrial cancer. Her most cited work, “Extended Venous Thromboembolism Prophylaxis after Robotic Staging for Endometrial Cancer” (2023), addresses a critical clinical question: whether extended postoperative enoxaparin reduces the incidence of venous thromboembolism (VTE) compared to a single preoperative dose following robotic staging. By comparing these two prophylactic regimens, Palmieri provides actionable evidence to guide postoperative management, directly impacting patient safety and recovery protocols. This study, with 5 citations, underscores her commitment to high-quality, practice-changing research in minimally invasive surgery. Palmieri’s contributions are particularly valuable in an era where robotic staging is increasingly standard, yet VTE risk remains a significant concern. Her work not only advances knowledge in gynecologic oncology but also exemplifies how targeted clinical studies can refine surgical standards. For students and researchers, Palmieri’s research demonstrates the power of asking precise, outcome-driven questions to improve real-world patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Extended Venous Thromboembolism Prophylaxis after Robotic Staging for Endometrial Cancer
5 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago